BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16445766)

  • 1. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.
    Otley CC; Berg D; Ulrich C; Stasko T; Murphy GM; Salasche SJ; Christenson LJ; Sengelmann R; Loss GE; Garces J;
    Br J Dermatol; 2006 Mar; 154(3):395-400. PubMed ID: 16445766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
    Otley CC; Griffin MD; Charlton MR; Edwards BS; Neuburg M; Stasko T;
    Br J Dermatol; 2007 Dec; 157(6):1183-8. PubMed ID: 17916206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The historical link between solid-organ transplantation, immunosuppression, and skin cancer.
    Randle HW
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):595-7. PubMed ID: 15061841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
    Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients].
    Lapointe AK; Hofbauer G; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Pascual M; Pelloni F; Serra A; Laffitte E
    Rev Med Suisse; 2010 Apr; 6(246):854-9. PubMed ID: 20455382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer and immunosuppression.
    Gerlini G; Romagnoli P; Pimpinelli N
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):127-36. PubMed ID: 15978830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of skin cancer in solid organ transplant recipients.
    Traywick C; O'Reilly FM
    Dermatol Ther; 2005; 18(1):12-8. PubMed ID: 15842608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
    Kovach BT; Sams HH; Stasko T
    Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for skin cancer in organ transplant recipients in Denmark].
    Horn J; Lock-Andersen J; Rasmussen K; Jemec GB
    Ugeskr Laeger; 2005 Jun; 167(25-31):2762-5. PubMed ID: 16014261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.
    Veness MJ; Harris D
    Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of skin cancer after organ transplantation.
    Lumbang W; Stasko T
    G Ital Dermatol Venereol; 2011 Oct; 146(5):341-52. PubMed ID: 21956271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skin cancer and other skin disorders in patients following solid organ transplantation].
    de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline quality of life and anxiety in solid organ transplant recipients: a pilot study.
    O'Reilly F; Traywick C; Pennie ML; Foster JK; Chen SC
    Dermatol Surg; 2006 Dec; 32(12):1480-5. PubMed ID: 17199656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
    Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin surveillance of a U.K. paediatric transplant population.
    Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
    Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy.
    Otley CC; Maragh SL
    Dermatol Surg; 2005 Feb; 31(2):163-8. PubMed ID: 15762208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.
    McKenna KE
    Photodermatol Photoimmunol Photomed; 2004 Dec; 20(6):289-96. PubMed ID: 15533236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.